2017
DOI: 10.1016/j.diagmicrobio.2016.10.021
|View full text |Cite
|
Sign up to set email alerts
|

First case of Roussoella percutanea bursitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
6
0

Year Published

2017
2017
2019
2019

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 14 publications
1
6
0
Order By: Relevance
“…Roussoella percutanea is a novel opportunistic pathogen reported in 2014 as an etiologic agent of subcutaneous infection in immunosuppressed patients (20,21). Also, in the present study the first case of keratitis due to R. percutanea was observed.…”
Section: Discussionsupporting
confidence: 68%
“…Roussoella percutanea is a novel opportunistic pathogen reported in 2014 as an etiologic agent of subcutaneous infection in immunosuppressed patients (20,21). Also, in the present study the first case of keratitis due to R. percutanea was observed.…”
Section: Discussionsupporting
confidence: 68%
“…Three reports of black fungal bursitis were found in the English literature [ 8 10 ] (Table 2 ). A patient with olecranon bursitis had a long history of post-traumatic non-infectious bursitis at the olecranon, and the fungus infected the pre-existing fluid accumulated in the bursa.…”
Section: Discussionmentioning
confidence: 99%
“…The joint guidelines of the European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group and the European Confederation of Medical Mycology on the management of subcutaneous phaeohyphomycosis ( 9 ) recommended surgical resection (recommendation AII) along with oral azoles in immunosuppressed patients to prevent dissemination of disease (recommendation BIII). In vitro susceptibility testing, conducted for 3 isolates by Ahmed et al ( 2 ) and Almagro-Molto et al ( 7 ), revealed that P. percutanea exhibited low MIC to itraconazole, voriconazole, and posaconazole (Table). Therefore, itraconazole and posaconazole can be used in patients receiving other liver-metabolized drug therapies.…”
mentioning
confidence: 99%
“…We searched published literature on Medline and PubMed for subcutaneous phaeohyphomycoses caused by P. percutanea or R. percutanea and identified 5 cases (Table). All 5 patients originated from tropical countries including the Caribbean islands ( 5 ), Republic of the Congo ( 6 ), Somalia ( 7 ), and India ( 2 , 8 ). Including these 5 with the case-patients we identified from culture and our study patient, 7 of 10 total cases originated in India.…”
mentioning
confidence: 99%
See 1 more Smart Citation